Published in Oncol Lett on May 17, 2017
KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol (2004) 101.91
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (2003) 82.89
The UCSC Table Browser data retrieval tool. Nucleic Acids Res (2004) 25.12
Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics (2006) 22.61
The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol (2007) 16.46
An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics (2003) 15.42
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol (2008) 11.46
STRING: a database of predicted functional associations between proteins. Nucleic Acids Res (2003) 9.45
miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res (2008) 8.97
Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One (2010) 6.61
The database of experimentally supported targets: a functional update of TarBase. Nucleic Acids Res (2008) 5.65
Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol (2011) 5.57
The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4. Nat Genet (2006) 5.36
Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev (2001) 5.09
The molecular biology of the CCAAT-binding factor NF-Y. Gene (1999) 4.36
A general framework for multiple testing dependence. Proc Natl Acad Sci U S A (2008) 4.27
Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci U S A (1999) 3.91
Why do hubs tend to be essential in protein networks? PLoS Genet (2006) 3.29
Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol (2012) 2.46
Cytoscape: software for visualization and analysis of biological networks. Methods Mol Biol (2011) 2.43
A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis (2008) 2.31
Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer. J Clin Oncol (2010) 1.95
KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants. Gynecol Oncol (2006) 1.80
Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas. Br J Cancer (2008) 1.75
Thinking outside the cell: how cadherins drive adhesion. Trends Cell Biol (2012) 1.72
The kinetochore and cancer: what's the connection? Curr Opin Cell Biol (2005) 1.68
Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth. Mol Biol Cell (2005) 1.68
Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins. Int J Cell Biol (2012) 1.58
Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells. BMC Med Genomics (2009) 1.55
Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells. J Mol Med (Berl) (2005) 1.18
Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer. Oncol Rep (2012) 1.16
First-line treatment of advanced ovarian cancer: current research and perspectives. Expert Rev Anticancer Ther (2010) 1.15
Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis. Biochem Pharmacol (2009) 1.11
MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer. Oncotarget (2014) 1.07
Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis. Int J Gynecol Pathol (2007) 1.06
Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells. Int J Oncol (2013) 1.06
Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma. J Mol Med (Berl) (2011) 1.06
NF-Y dependent epigenetic modifications discriminate between proliferating and postmitotic tissue. PLoS One (2008) 1.05
Estrogen receptor alpha expression in ovarian cancer predicts longer overall survival. Pathol Oncol Res (2011) 0.98
Poor survival with wild-type TP53 ovarian cancer? Gynecol Oncol (2013) 0.97
Wild-type tumor repressor protein 53 (Trp53) promotes ovarian cancer cell survival. Endocrinology (2012) 0.95
NF-YA underlies EZH2 upregulation and is essential for proliferation of human epithelial ovarian cancer cells. Mol Cancer Res (2013) 0.93
Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer. Mol Oncol (2011) 0.89
Expression levels of NF-Y target genes changed by CDKN1B correlate with clinical prognosis in multiple cancers. Genomics (2009) 0.87
Expression of protocadherin-9 and protocadherin-17 in the nervous system of the embryonic zebrafish. Gene Expr Patterns (2009) 0.86
FZD7 drives in vitro aggressiveness in Stem-A subtype of ovarian cancer via regulation of non-canonical Wnt/PCP pathway. Cell Death Dis (2014) 0.85
Characterization of microRNA expression in serous ovarian carcinoma. Int J Mol Med (2014) 0.81
Analysis of UHRF1 expression in human ovarian cancer tissues and its regulation in cancer cell growth. Tumour Biol (2015) 0.81
Overexpression of centromere protein K (CENPK) in ovarian cancer is correlated with poor patient survival and associated with predictive and prognostic relevance. PeerJ (2015) 0.76